NEW YORK, Nov. 20, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
This study of the academic and pharma/biotech sectors in North America and Europe provides an analysis of the market for primary cells and an assessment of the brand equity for the leading companies who serve this market. This report also describes the emerging market for stem cell-derived differentiated cells, a potential threat—or opportunity—for this market.
This study explores the following market analytics:
• The number of researchers who currently or plan to use primary cells in their research• Proportion of researchers/labs who purchase primary cells• Annual lab budget associated with primary cell purchase• Market size, in terms of revenue, based on 2012• Supplier share in terms of revenue• Market growth in terms of revenue in the next 12 months (through 2013)
This study explores the following product analytics:
• The different types of cells used in life science research• Motivation for primary cell use• The motivation for—or barriers preventing—the purchase of primary cells• The top primary cell types used• The leading suppliers of primary cells• Customer satisfaction with primary cell pro
Copyright©2012 PR Newswire.
All rights reserved